These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 9120806)

  • 21. Pharmacokinetics and neural blockade after subarachnoid lidocaine in the rhesus monkey. III. Effects of phenylephrine.
    Denson DD; Turner PA; Bridenbaugh PO; Thompson GA
    Anesth Analg; 1984 Feb; 63(2):129-33. PubMed ID: 6691578
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In-vitro permeability to salicylic acid of human, rodent, and shed snake skin.
    Harada K; Murakami T; Kawasaki E; Higashi Y; Yamamoto S; Yata N
    J Pharm Pharmacol; 1993 May; 45(5):414-8. PubMed ID: 8099958
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Percutaneous absorption of salicylates from some commercially available topical products containing methyl salicylate or salicylate salts in rats.
    Megwa SA; Benson HA; Roberts MS
    J Pharm Pharmacol; 1995 Nov; 47(11):891-6. PubMed ID: 8708981
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Radial spread of sodium lauryl sulfate after topical application.
    Patil S; Singh P; Maibach H
    Pharm Res; 1995 Dec; 12(12):2018-23. PubMed ID: 8786982
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics of lidocaine following the application of 5% lidocaine patches to cats.
    Ko JC; Maxwell LK; Abbo LA; Weil AB
    J Vet Pharmacol Ther; 2008 Aug; 31(4):359-67. PubMed ID: 18638297
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Local deep tissue penetration of compounds after dermal application: structure-tissue penetration relationships.
    Singh P; Roberts MS
    J Pharmacol Exp Ther; 1996 Nov; 279(2):908-17. PubMed ID: 8930199
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effects of subarachnoid lidocaine and phenylephrine on spinal cord and cerebral blood flow in dogs.
    Dohi S; Matsumiya N; Takeshima R; Naito H
    Anesthesiology; 1984 Sep; 61(3):238-44. PubMed ID: 6476432
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improved ocular: systemic absorption ratio of timolol by viscous vehicle and phenylephrine.
    Kyyrönen K; Urtti A
    Invest Ophthalmol Vis Sci; 1990 Sep; 31(9):1827-33. PubMed ID: 2211028
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of ion pairing with alkylamines on the in-vitro dermal penetration and local tissue disposition of salicylates.
    Megwa SA; Cross SE; Whitehouse MW; Benson HA; Roberts MS
    J Pharm Pharmacol; 2000 Aug; 52(8):929-40. PubMed ID: 11007063
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effect of salicylic acid on the blanching effect of flumethasone pivalate (author's transl)].
    Wienert V; Blazek V
    Arch Dermatol Res; 1981; 271(1):19-27. PubMed ID: 7294880
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of stratum corneum and dermal microvascular perfusion in penetration and tissue levels of water-soluble drugs investigated by microdialysis.
    Morgan CJ; Renwick AG; Friedmann PS
    Br J Dermatol; 2003 Mar; 148(3):434-43. PubMed ID: 12653734
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phenylephrine tumescence in split-thickness skin graft donor sites in surgery for burn injury- a concentration finding study.
    Mitchell RT; Funk D; Spiwak R; Logsetty S
    J Burn Care Res; 2011; 32(1):129-34. PubMed ID: 21131843
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Estimation of intradermal disposition kinetics of drugs: I. Analysis by compartment model with contralateral tissues.
    Nakayama K; Matsuura H; Asai M; Ogawara K; Higaki K; Kimura T
    Pharm Res; 1999 Feb; 16(2):302-8. PubMed ID: 10100318
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical pharmacokinetics of the salicylates.
    Needs CJ; Brooks PM
    Clin Pharmacokinet; 1985; 10(2):164-77. PubMed ID: 3888490
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Extent of cutaneous metabolism during percutaneous absorption of xenobiotics.
    Bronaugh RL; Stewart RF; Storm JE
    Toxicol Appl Pharmacol; 1989 Jul; 99(3):534-43. PubMed ID: 2749738
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Peripheral assessment of phenylephrine-induced vasoconstriction by laser Doppler flowmetry and its potential relevance to homeostatic mechanisms.
    Silverman DG; Jotkowitz AB; Freemer M; Gutter V; O'Connor TZ; Braverman IM
    Circulation; 1994 Jul; 90(1):23-6. PubMed ID: 8026002
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Percutaneous absorption of topically applied NSAIDS and other compounds: role of solute properties, skin physiology and delivery systems.
    Roberts MS; Cross SE
    Inflammopharmacology; 1999; 7(4):339-50. PubMed ID: 17657437
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of in vitro human skin membranes to model and predict the effect of changing blood flow on the flux and retention of topically applied solutes.
    Cross SE; Roberts MS
    J Pharm Sci; 2008 Aug; 97(8):3442-50. PubMed ID: 18064682
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Disposition kinetics in the rat fetus.
    Nanbo T
    Reprod Toxicol; 1991; 5(5):411-6. PubMed ID: 1806150
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of BQ-123 and Ro 47-0203 (bosentan) on endothelin-induced vasoconstriction in the rat skin.
    Lawrence E; Brain SD
    Eur J Pharmacol; 1994 Jul; 260(1):103-6. PubMed ID: 7957619
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.